Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 7-(alpha-(2-aminomethylphenyl)acetamido)-3-((1-carboxymethyltetrazol-5-ylthio)methyl)-3-cephem-4-carboxylic Acid
2. Bl-s 786
3. Bl-s786r
4. Cefaronide
5. Ceforanide, Monosodium Salt
1. 60925-61-3
2. Precef
3. Ceforanido
4. Ceforanidum
5. Ceforanidum [inn-latin]
6. Ceforanido [inn-spanish]
7. Bl-s786
8. (6r,7r)-7-[[2-[2-(aminomethyl)phenyl]acetyl]amino]-3-[[1-(carboxymethyl)tetrazol-5-yl]sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
9. Chebi:3495
10. 7-(o-(aminomethyl)phenylacetamido)-3-(((1-(carboxymethyl)-1h-tetrazol-5-yl)thio)methyl)-3-cephem-4-carboxylic Acid
11. 8m1yf8951v
12. Nsc-760049
13. (6r,7r)-7-{2-[2-(aminomethyl)phenyl]acetamido}-3-({[1-(carboxymethyl)-1h-1,2,3,4-tetrazol-5-yl]sulfanyl}methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
14. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-(((2-(aminomethyl)phenyl)acetyl)amino)-3-(((1-(carboxymethyl)-1h-tetrazol-5-yl)thio)methyl)-8-oxo-, (6r-trans)-
15. 7-[o-(aminomethyl)phenylacetamido]-3-[[[1-(carboxymethyl)-1h-tetrazol-5-yl]thio]methyl]-3-cephem-4-carboxylic Acid
16. 7beta-[2-(aminomethyl)phenyl]acetamido-3-{[1-(carboxymethyl)-1h-tetrazol-5-yl]sulfanyl}methyl-3,4-didehydrocepham-4-carboxylic Acid
17. Bl-s 786
18. Precef (tn)
19. Ceforanide (usp/inn)
20. Sr-01000872614
21. Unii-8m1yf8951v
22. Ceforanide [usan:usp:inn:ban]
23. Ncgc00016897-01
24. Cas-60925-61-3
25. (6r,7r)-7-(2-(alpha-amino-o-tolyl)acetamido)-3-(((1-(carboxymethyl)-1h-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid
26. Ceforanide [mi]
27. Ceforanide [inn]
28. Prestwick0_000470
29. Prestwick1_000470
30. Prestwick2_000470
31. Prestwick3_000470
32. Ceforanide [usan]
33. Dsstox_cid_2760
34. Ceforanide [vandf]
35. Ceforanide [mart.]
36. Ceforanide(200mg)
37. Ceforanide [usp-rs]
38. Ceforanide [who-dd]
39. Dsstox_rid_76719
40. Dsstox_gsid_22760
41. Bspbio_000580
42. (6r-trans)-7-(((2-(aminomethyl)phenyl)acetyl)amino)-3-(((1-(carboxymethyl)-1h-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid
43. Schembl122072
44. Spbio_002519
45. Bpbio1_000638
46. Ceforanide [orange Book]
47. Chembl1201046
48. Dtxsid1022760
49. Gtpl12218
50. Ceforanide [usp Impurity]
51. Hms1569m22
52. Hms2096m22
53. Hms3713m22
54. (6r,7r)-7-(2-(2-(aminomethyl)phenyl)acetamido)-3-(((1-(carboxymethyl)-1h-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
55. Hy-b1297
56. Zinc3830434
57. Tox21_110670
58. Ccg-220470
59. Db00923
60. Nsc 760049
61. Ncgc00179514-05
62. (6r,7r)-7-({[2-(aminomethyl)phenyl]acetyl}amino)-3-({[1-(carboxymethyl)-1h-tetrazol-5-yl]sulfanyl}methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
63. (6r,7r)-7-({[2-(aminomethyl)phenyl]acetyl}amino)-3-({[1-(carboxymethyl)-1h-tetrazol-5-yl]thio}methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
64. As-15783
65. Ab00513845
66. Cs-0013066
67. S5081
68. C06884
69. D00259
70. D81832
71. 925c613
72. A913663
73. Q5057287
74. Sr-01000872614-2
75. Sr-01000872614-3
76. Brd-k37848908-001-03-1
77. (6r,7r)-7-(2-(.alpha.-amino-o-tolyl)acetamido)-3-(((1-(carboxymethyl)-1h-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid
78. (6r,7r)-7-(2-(2-(aminomethyl)phenyl)acetamido)-3-(((1-(carboxymethyl)-1h-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid
79. 7-[[2-[2-(aminomethyl)phenyl]acetyl]amino]-3-[[1-(carboxymethyl)tetrazol-5-yl]sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
Molecular Weight | 519.6 g/mol |
---|---|
Molecular Formula | C20H21N7O6S2 |
XLogP3 | -3.2 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 12 |
Rotatable Bond Count | 10 |
Exact Mass | 519.09947376 g/mol |
Monoisotopic Mass | 519.09947376 g/mol |
Topological Polar Surface Area | 244 Ų |
Heavy Atom Count | 35 |
Formal Charge | 0 |
Complexity | 905 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
For the treatment of infections caused by susceptible organisms.
Ceforanide is a semisynthetic second-generation cephalosporin. The cephalosporins are bactericidal drugs with both gram-positive and gram-negative activity. They inhibit bacterial cell wall synthesis in a way similar to the penicillins.
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
J - Antiinfectives for systemic use
J01 - Antibacterials for systemic use
J01D - Other beta-lactam antibacterials
J01DC - Second-generation cephalosporins
J01DC11 - Ceforanide
Absorption
Rapidly absorbed following intramuscular injection.
The major drug elimination route was urinary excretion with 85% of the dose being excreted unchanged in the urine within 12 hr, and no metabolites with antibiotic activity were observed in urine.
2.6 to 2.98 hours
The bactericidal activity of ceforanide results from the inhibition of cell wall synthesis via affinity for penicillin-binding proteins (PBPs).
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Ceforanide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ceforanide, including repackagers and relabelers. The FDA regulates Ceforanide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ceforanide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Ceforanide supplier is an individual or a company that provides Ceforanide active pharmaceutical ingredient (API) or Ceforanide finished formulations upon request. The Ceforanide suppliers may include Ceforanide API manufacturers, exporters, distributors and traders.
click here to find a list of Ceforanide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Ceforanide DMF (Drug Master File) is a document detailing the whole manufacturing process of Ceforanide active pharmaceutical ingredient (API) in detail. Different forms of Ceforanide DMFs exist exist since differing nations have different regulations, such as Ceforanide USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Ceforanide DMF submitted to regulatory agencies in the US is known as a USDMF. Ceforanide USDMF includes data on Ceforanide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Ceforanide USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Ceforanide suppliers with USDMF on PharmaCompass.
A Ceforanide written confirmation (Ceforanide WC) is an official document issued by a regulatory agency to a Ceforanide manufacturer, verifying that the manufacturing facility of a Ceforanide active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Ceforanide APIs or Ceforanide finished pharmaceutical products to another nation, regulatory agencies frequently require a Ceforanide WC (written confirmation) as part of the regulatory process.
click here to find a list of Ceforanide suppliers with Written Confirmation (WC) on PharmaCompass.
Ceforanide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ceforanide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ceforanide GMP manufacturer or Ceforanide GMP API supplier for your needs.
A Ceforanide CoA (Certificate of Analysis) is a formal document that attests to Ceforanide's compliance with Ceforanide specifications and serves as a tool for batch-level quality control.
Ceforanide CoA mostly includes findings from lab analyses of a specific batch. For each Ceforanide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ceforanide may be tested according to a variety of international standards, such as European Pharmacopoeia (Ceforanide EP), Ceforanide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ceforanide USP).
LOOKING FOR A SUPPLIER?